About ADDAX Biosciences
ADDAX Biosciences is a Healthcare company based in Turin (Italy) founded in 2017. Its chief executive, as recorded, is Gianni Bussolati. ADDAX Biosciences offers products and services including GAF. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Glycobiology.
Company details
ADDAX Biosciences was founded in 2017 in Turin, Italy, within the biotechnology sector. A patented non-toxic fixative is developed as a substitute for formalin, enabling histological, immunohistochemical, and molecular analyses with reduced health risks. Operations focus on laboratory applications to enhance worker safety and patient outcomes. Collaborations with research institutions are maintained to expand technology uses across various fields.
- Headquarters Turin, Italy
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website addaxbio.com
- InvestorsFT Partners
& 2 more
Products & Services of ADDAX Biosciences
ADDAX Biosciences offers a comprehensive portfolio of products and services, including GAF.
Safe, non-toxic solution for preserving tissue in medical diagnostics.
Funding Insights of ADDAX Biosciences
- Total Rounds 3
- First Round $56,095
(Jan 2020)
- Investors Count 3
All 3 funding rounds of ADDAX Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | Seed | – | FT Partners | – | |
| Aug 2020 | $59,518 | Grant | – | – | |
| Jan 2020 | $56,095 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in ADDAX Biosciences
ADDAX Biosciences has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include FT Partners, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Investment banking services focused on fintech are provided. | 2001 | ftpartners.com | San Francisco, United States | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for ADDAX Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ADDAX Biosciences
1 people are tracked at ADDAX Biosciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
Gianni Bussolati | CEO | Leadership |
Complete people profiles for ADDAX Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ADDAX Biosciences
3 dated milestones of ADDAX Biosciences across 7 years, from founding to its latest funding, stage changes and deals.
- Founded ADDAX Biosciences is founded.
- Funding First funding round of $56K.
- Funding Latest funding round, Seed,.
Web traffic of ADDAX Biosciences
The website of ADDAX Biosciences (addaxbio.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 39.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ADDAX Biosciences
ADDAX Biosciences was founded in 2017 and raised its 1st funding round 3 years after it was founded.
ADDAX Biosciences is headquartered in Turin, Italy. It is registered at Turin, Piedmont, Italy.
Gianni Bussolati is the CEO of ADDAX Biosciences, as recorded in our data.
ADDAX Biosciences was founded in 2017 in Turin, Italy, within the biotechnology sector. A patented non-toxic fixative is developed as a substitute for formalin, enabling histological, immunohistochemical, and molecular analyses with reduced health risks. Operations focus on laboratory applications to enhance worker safety and patient outcomes. Collaborations with research institutions are maintained to expand technology uses across various fields.
ADDAX Biosciences offers GAF.
ADDAX Biosciences has 3 investors. Key investors include FT Partners, European Union, and EIC Fund.